|
|
no spill waste discharge line disposable discharge drain for mobile dialysis machines There are currently no reviews for this Innovation.
| no spill waste discharge line
disposable discharge drain for mobile dialysis machines |
|
The only patented F.D.A. and Medicare approved disposable discharge device for at home and mobile dialysis users that prevents spills and contaminatation. |
 Annual Sales Forecast for USA * | Innovation Status |
Idea |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
Development
Status |
Proprietary
Protection Status |
Concept
Score |
| Ultra Low |
$0 |
$9,500 |
$53,000 |
4 of 5
Manufacturing Ready
|
5 of 5
Granted Patent Claims
|
44 29 is
Average
|
| Low Support |
$130,000 |
$270,000 |
$470,000 |
| Medium Support |
$1.2 M |
$1.8 M |
$2.7 M |
| High Support |
$3.4 M |
$4.9 M |
$7.1 M |
Remaining Time & Cost to First Sale |
| Ultra High |
$6.3 M |
$9.3 M |
$13.3 M |
6 mos-1 yr
|
$10k-$100k
|
no spill waste discharge line
- disposable discharge drain for mobile dialysis machines
Final Decision Maker: physicians
Our discharge device allows home and mobile dialysis patients the freedom not to be tied down to one location. Currently dialysis patients have no secure way to fasten the discharge line to their mobile dialysis unit to prevent it from falling on the floor and causing a hazardous condition. Our simple patented discharge device adapts to all mobile and home dialysis discharge machines. Attach the discharge hose to our simple sterile disposable connector clip to any smooth surface such as a toilet, lavatory, tub or shower. The secure suction mount prevents the tube from falling to the floor and prevents spillage and kinking of the tubing that occurs from other techniques. It keeps the tubing from contacting non-sterile surfaces which could result in infections. A review of the device by the Harvard Medical School says "this represents a significant improvement in quality, safety and outcomes".
| $3.00 for each unit | Seeking: Purchase, Distribution, Manufacturing/R&D |
|
* Consumption sales forecast. Does not include "Random" events or "Inventory Fill". Forecast is for Year 1 for Large or Year 2 for Small Companies.
Forecast should be read as ..."With Low marketing support there is an 80% odds of achieving sales of at least... |
| Listing #: USA.76.041509.003 |
Page 1 of 5 |
Date Posted: 2009-04-15 |
|
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Report Assumptions and Inventor(s) Commentary
|
|
| Inventor(s) Assumptions |
"Most Likely"
Estimate |
Confidence |
Inventor(s) Commentary
Data Source or Basis for Assumptions |
| # of Possible Final Decision Makers |
11,000 |
60% |
Based on data from the American Society of Nephrology " these are physicans who treat dialysis patients".
|
| Revenue per First Purchase |
$1,800.00 |
40% |
2004 Kalorama worldwide dialysis study, number of dialysis physicians.We estimated growth from 2004@ 50% based on anecdotal evidence from local physicians. |
| % that will Repeat |
50% |
30% |
Based on personal experience with a family member. |
| Number of Annual Repeats |
12 |
70% |
Due to U.S. Medicare laws all diagnosed renal patients receive supplies indefinitely. |
| Revenue per Repeat Purchase |
$1,800.00 |
40% |
2004 Kalorama worldwide dialysis study, number of dialysis physicians.We estimated growth from 2004@ 50% based on anecdotal evidence from local physicians. |
| Reseller (Trade) Margin |
21% |
30% |
Based on data byPlanet Eureka segament |
| Producer Profit (EBITD) |
21% |
30% |
Based on data provided by Planet Eureka Ind segament |
| |
| Innovation Status |
|
Development
Status |
4 of 5
Manufacturing Ready
|
FDA Approved 510 Class 2 device and medicare approved. Injection molds and prototypes made and tested by Univ.of New Orleans. Only
production and marketing remain. |
| Cost to First Sale (remaining) |
$10k-$100k |
90% |
Based on quotes from F.D.A. approved manufacturing companies. |
| Time to First Sale (remaining) |
6 mos-1 yr |
70% |
Marketing and manufacturing |
| Confidence in Concept Claims made in description |
90% |
Product has been tested, patented, F.D.A. and Medicare approved. Brother of the inventor is a mobile dialysis user and has also tested the product. |
Proprietary
Protection Status |
5 of 5
Granted Patent Claims
|
Patent cover all types of medical discharge. |
| Concept Score & Diagnostics |
|
|
| Concept Diagnostics |
Red |
Yellow |
Green |
| Percentile Group |
Bottom 40% |
Middle 40% |
Top 20% |
| Overt Benefit |
|
 |
|
| Reason to Believe |
 |
|
|
| Dramatic Difference |
|
|
|
|
| Listing #: USA.76.041509.003 |
Page 2 of 5 |
Date Posted: 2009-04-15 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Inventor Commentary & Alternative Development Scenarios
|
|
| Inventor(s) Sales Goals |
| Minimum Goal |
$3 M |
Current GOAL |
$14 M |
Illustration of secure connector clip in use. |
|
CURRENT SALES FORECAST |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$9,500 |
$53,000 |
| Low Support |
$130,000 |
$270,000 |
$470,000 |
| Medium Support |
$1.2 M |
$1.8 M |
$2.7 M |
| High Support |
$3.4 M |
$4.9 M |
$7.1 M |
| Ultra High |
$6.3 M |
$9.3 M |
$13.3 M |
If MARKETING CONCEPT Improved (Increase Concept Score by +20 Points) |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$14,000 |
$77,000 |
| Low Support |
$200,000 |
$390,000 |
$690,000 |
| Medium Support |
$1.7 M |
$2.6 M |
$3.9 M |
| High Support |
$4.8 M |
$7.2 M |
$10.3 M |
| Ultra High |
$9.1 M |
$13.4 M |
$19.4 M |
If PRODUCT/SERVICE Improved (Increase Repeat Rate & Number of Repeats by 30% and Revenue Per Purchase 20%) |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$18,000 |
$100,000 |
| Low Support |
$250,000 |
$510,000 |
$900,000 |
| Medium Support |
$2.2 M |
$3.4 M |
$5.0 M |
| High Support |
$6.2 M |
$9.3 M |
$13.7 M |
| Ultra High |
$11.5 M |
$17.4 M |
$25.3 M |
If MARKETING CONCEPT and PRODUCT/SERVICE Improved (Increase Concept +20 Points, Repeat Rate & Number of repeats by 30% and Revenue per purchase 20%) |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$27,000 |
$140,000 |
| Low Support |
$360,000 |
$730,000 |
$1.3 M |
| Medium Support |
$3.2 M |
$4.9 M |
$7.5 M |
| High Support |
$9.0 M |
$13.3 M |
$19.7 M |
| Ultra High |
$16.6 M |
$24.9 M |
$36.7 M |
|
| Listing #: USA.76.041509.003 |
Page 3 of 5 |
Date Posted: 2009-04-15 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Additional Details
|
|
| Fair Market Royalty (%) |
| |
Conservative - 80% Odds
Royalty Percentage |
Most Likely - 50% Odds
Royalty Percentage |
Aggressive - 20% Odds
Royalty Percentage |
| At CURRENT State & Status |
2.2% |
4% |
5.9% |
Sales & Marketing
Support Level |
Annual Inventor Royalty Revenue |
3 Year Value
to Inventor
If 50% Odds |
| 80% Odds |
50% Odds |
20% Odds |
| Ultra Low Support |
$200 |
$560 |
$1,200 |
$1,700 |
| Low Support |
$3,400 |
$7,700 |
$14,000 |
$23,000 |
| Medium Support |
$27,000 |
$52,000 |
$83,000 |
$150,000 |
| High Support |
$73,000 |
$140,000 |
$220,000 |
$420,000 |
| Ultra High Support |
$140,000 |
$260,000 |
$420,000 |
$780,000 |
| Sales & Marketing Support Level Assumptions |
| Sales & Marketing Support Level Assumptions |
Sample Numbers |
% Aware x
% Distribution
(Aware & Able) |
Inventor
Confidence |
| % Distribution |
% Awareness |
| Ultra Low Support (Word of Mouth) |
5% |
3% |
0.2% |
% |
| Low Support (Small Company) |
20% |
10% |
2% |
N/A |
| Medium Support (Medium Sized Company) |
50% |
25% |
13% |
N/A |
| High Support (Large Company) |
75% |
45% |
34% |
N/A |
| Ultra High Support (Mega or Niche) |
90% |
70% |
63% |
N/A |
|
Graph of EQUIVALENT (Awareness x Distribution) Combinations
 |
NAICS Industry Codes
For This Invention |
| 33451 - Navigational, Measuring, Electromedical, and Cont... |
| 33911 - Medical Equipment and Supplies Manufacturing |
| 42345 - Medical, Dental, and Hospital Equipment and Suppl... |
| 62111 - Offices of Physicians |
| 62149 - Other Outpatient Care Centers |
|
| Patent Numbers that apply to this Product/Service |
| 6,926,239 |
| 7,090,180B2 |
| |
| |
| |
|
| Inventor(s) PEDIGREE |
| Years EXPERIENCE in related industry |
10 |
| GRANTED Patents |
4 |
| Licensing Deals SIGNED |
0 |
| Innovations that have SHIPPED |
0 |
|
For USA Patents: Utility Patent = 7 digit number, Design Patent starts with D, Planet Patent starts with PP. Provisional Application "61/xxx,xxx", Non provisional application "12/xxx,xxx", Design patent application "29/xxx,xxx"
|
|
CAUTION: This Merwyn Business Simulation Research Report includes no warranty or guarantee. Results and opinions should be considered rough and directional in nature. This is because the report is based upon inventor-supplied data and simplified modeling methods. If you are looking to invest, distribute, purchase or become involved with this innovation, in any way, we strongly urge you to validate the inventor data and sales forecasts BEFORE committing yourself or your resources. Merwyn Research, Inc. shall not be responsible for any liability or damages arising out of the failure to perform such investigation and validation. Changes in the concept description, product, pricing, or input assumptions will almost certainly change results.
|
| Listing #: USA.76.041509.003 |
Page 4 of 5 |
Date Posted: 2009-04-15 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Additional Forecasts for Other Countries
|
|
 Annual Sales - Probability Forecast - Canada |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$1,500 |
$8,400 |
| Low Support |
$21,000 |
$43,000 |
$75,000 |
| Medium Support |
$190,000 |
$290,000 |
$420,000 |
| High Support |
$530,000 |
$780,000 |
$1.1 M |
| Ultra High |
$1.0 M |
$1.5 M |
$2.1 M |
 Annual Sales - Probability Forecast - United Kingdom |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$2,700 |
$15,000 |
| Low Support |
$38,000 |
$76,000 |
$130,000 |
| Medium Support |
$340,000 |
$510,000 |
$750,000 |
| High Support |
$950,000 |
$1.4 M |
$2.0 M |
| Ultra High |
$1.8 M |
$2.6 M |
$3.8 M |
Forecast are calculated based on population, (PPP) purchasing power parity, International Trade, Urbanization and the Human Growth Index.
Forecast can be skewed for some industries, so for best results, adjusting the number of final decision makers for every country is recommended.
| Listing #: USA.76.041509.003 |
Page 5 of 5 |
Date Posted: 2009-04-15 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
